Penile rehabilitation therapy following radical prostatectomy

Disability and Rehabilitation

Volumn 32, Issue 14, 2010, Pages 1204-1208

  Pace, Gianna ^a,b   Rosso, Alessandro Del ^a,b   Vicentini, Carlo ^a,b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Mazzini Hospital   (Italy)

Author keywords

Nerve sparing techniques; PDE 5 inhibitors; Penile rehabilitation therapy; Radical prostatectomy

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SILDENAFIL; SULFONE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HUMAN; MALE; MIDDLE AGED; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL;

AGED; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSTATECTOMY; PURINES; SULFONES;

EID: 77952925509     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638280903511594     Document Type: Article

References (25)

1. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-1328.
2. Mulcahy JJ. Erectile function after radical prostatectomy. Semin Urol Oncol 2000;18:71-75.
3. Campbell HE. Clinical monograph for drug formulary review: erectile dysfunction agents. J Manag Care Pharm 2005;11:151-171.
4. Mulhall JP. Penile rehabilitation following radical prostatectomy. Curr Opin Urol 2008;18:613-620.
5. Wang R. Penile rehabilitation after radical prostatectomy: where do we stand and where are we going? J Sex Med 2007;4:1085-1097.
6. Rambhatla A, Kovanecz I, Ferrini M, Gonzalez-Cadavid NF, Rajfer J. Rationale for phosphodiesterase 5 inhibitor use postradical prostatectomy: experimental and clinical review. Int J Impot Res 2008;20:30-34.
7. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-830.
8. Brewer ME, Kim ED. Penile rehabilitation therapy with PDE-V inhibitors following radical prostatectomy: proceed with caution. Adv Urol 2009;852437. Epub 2009 Jan 25.
9. Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G, Cao YC, Olsson C, Shabsigh R. Apoptosis in the rat penis after penile denervation. J Urol 1997;158:626-630.
10. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a postradical prostatectomy model of erectile dysfunction. J Urol 2003;169:1175-1179.
11. Burnett AL, Lue TF. Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgery. J Urol 2006;176:882-887.
12. Burnett AL. Neuroprotection and nerve grafts in the treatment of neurogenic erectile dysfunction. J Urol 2003;170: S31-S34; discussion S34.
13. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008;101:203-210.
14. Behr-Roussel D, Gorny D, Mevel K, Caisey S, Bernabé J, Burgess G, Wayman C, Alexandre L, Giuliano F. Chronic sildenafil improves erectile function and endothelium-depen-dent cavernosal relaxations in rats: lack of tachyphylaxis. Eur Urol 2005;47:87-91.
15. Vignozzi L, Filippi S, Morelli A, Ambrosini S, Luconi M, Vannelli GB, Donati S, Crescioli C, Zhang XH, Mirone V, Forti G, Maggi M. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med 2006;3:419-431.
16. Vignozzi L, Morelli A, Filippi S, Vannelli GB, Mungai S, Marini M, Boddi V, Forti G, Maggi M. Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. Int J Impot Res 2008;20:60-67.
17. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J. Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 2006;68:429-435.
18. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Jünemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int 2008;101:1279-1283.
19. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. Theuse of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005;2:532-540; discussion 540-542.
20. El-Bahnasawy MS, Ismail T, Elsobky E, Alzalouey EI, Bazeed MA. Prognostic factors predicting successful response to sildenafil after radical cystoprostatectomy. Scand J Urol Nephrol 2008;42:110-115.
21. Montorsi F, Salonia A, Zanoni M, Colombo R, Pompa P, Rigatti P. Counselling the patient with prostate cancer about treatment-related erectile dysfunction. Curr Opin Urol 2001;11:611-617.
22. Heathcote PS, Mactaggart PN, Boston RJ, James AN, Thompson LC, Nicol DL. Health-related quality of life in Australian men remaining disease-free after radical prostatectomy. Med J Aust 1998;168:477-478.
23. McCullough AR. Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 2001;28:613-627.
24. Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 2000;56:631-634.
25. Raina R, Lakin MM, Agarwal A, Sharma R, Goyal KK, Montague DK, Klein E, Zippe CD. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003;62:110-115.